ENDO INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.5 USD | +0.88% |
|
0.00% | 0.00% |
| Current month | +0.88% |
| 1 day | +0.88% | ||
| Current month | +0.88% |
1 week
28.25
28.50
1 month
27.0028.50
Current year
27.0028.50
1 year
27.0028.50
3 years
27.0028.50
5 years
27.0028.50
10 years
27.0028.50
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-05 | 28.5 | +0.88% | 199 |
| 24-07-01 | 28.25 | 0.00% | 103 |
Delayed Quote OTC Markets, July 05, 2024 at 09:30 am
More quotes
Endo, Inc. is a diversified specialty pharmaceutical company, which is engaged in transforming insights into life-enhancing therapies. It provides a comprehensive range of healthcare products, designed to meet the needs of patients across the United States. Its product categories include specialty medicines, sterile injectables, and generics. Its products include ADRENALIN CHLORIDE solution; ADREN ALIN; ALISKIREN tablets; ALLOPURINOL tablets, USP; ALPRAZOLAM ORALLY DISINTEGRATING tablets, USP CIV; ALVIMOPAN capsules; AMILORIDE HYDROCHLORIDE tablets, USP; APLISOL; ARGATROBAN injection; ASPIRIN & EXTENDED RELEASE DIPYRIDAMOLE capsules; AVEED; BACLOFEN TABLETS, USP; BENZTROPINE MESYLATE tablets, USP; BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE and TETRACYCLINE HYDROCHLORIDE capsules; BIVALIRUDIN injection; BREVITAL; BUPRENORPHINE HYDROCHLORIDE injection CIII; BUTALBITAL and ACETAMINOPHEN tablets; CALCITONIN SALMON injection, USP SYNTHETIC, and CANDESARTAN CILEXETIL tablets.
Sector
Drug Retailers
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 1.78B | |
| -56.87% | 9.58B | |
| -45.52% | 8.84B | |
| -24.76% | 6.63B | |
| -5.95% | 6.17B | |
| +87.00% | 5B | |
| -3.50% | 4.58B | |
| +1.56% | 4.4B | |
| -27.53% | 3.96B | |
| +2.28% | 2.85B |
- Stock Market
- Equities
- NDOI Stock
